We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Tumor Boards
Colleague Insights
Living Resources
Conferences
Nursing Perspectives
Video Expert Opinion
Sign in
Join now
Published in Metastatic Breast Cancer

Journal Scan / Research · February 07, 2023

Clinical Characteristics and Survival Outcomes in Patients With De Novo vs Metachronous Metastatic Breast Cancer

Breast Cancer Research and Treatment

 

 Save  Recommend
 Share

Additional Info

Breast Cancer Research and Treatment
Comparison between de novo and metachronous metastatic breast cancer: the presence of a primary tumour is not the only difference-a Dutch population-based study from 2008 to 2018
Breast Cancer Res Treat 2023 Jan 17;[EPub Ahead of Print], JS de Maar, M Luyendijk, BBM Suelmann, DEW van der Kruijssen, SG Elias, S Siesling, E van der Wall

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated